Aidan William Flynn, MD | |
80 Seymour Street, Hartford Hospital Cardiology Dept, Hartford, CT 06102-5037 | |
(860) 972-4398 | |
Not Available |
Full Name | Aidan William Flynn |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 80 Seymour Street, Hartford, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316252919 | NPI | - | NPPES |
001520964 | Medicaid | CT |
Mailing Address | Practice Location Address |
---|---|
Aidan William Flynn, MD Po Box 415933, Hartford Hospital Professional Services, Boston, MA 02241-5933 Ph: (860) 545-7602 | Aidan William Flynn, MD 80 Seymour Street, Hartford Hospital Cardiology Dept, Hartford, CT 06102-5037 Ph: (860) 972-4398 |
News Archive
Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon' of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.
The National Cancer Institute today launched a new drug formulary (the "NCI Formulary") that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
Five genetic regions have been identified that are unique to the most virulent strain of Clostridium difficile (C. difficile), the hospital superbug. Researchers writing in BioMed Central's open access journal Genome Biology studied the genome of the bacterium, looking for genes relating to motility, antibiotic resistance and toxicity.
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
› Verified 3 days ago
Gagandeep Singh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 114 Woodland St, Hartford, CT 06105 Phone: 860-714-7446 Fax: 860-714-1508 | |
Yixia Ye, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 31 Seymour St Ste 205, Hartford, CT 06106 Phone: 860-524-2610 | |
Andrew P Scatola, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 85 Jefferson Street, Hartford Hospital Cardiology Dept, Hartford, CT 06106 Phone: 860-972-1212 | |
Dr. David Jay Altszuler, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 85 Seymour St Ste 719, Hartford, CT 06106 Phone: 860-522-0604 Fax: 860-522-0604 | |
Dr. Nisha Dhanabalsamy, MBBS Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Seymour St, Hartford, CT 06102 Phone: 860-972-0549 | |
Sindhuja Palle, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 80 Seymour St, Hartford, CT 06106 Phone: 860-545-5000 | |
Dr. Jamie Matthew Roche, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 80 Seymour St, Hartford, CT 06102 Phone: 860-545-3359 |